Thrombopoietin Level in Young Patients Is Related to Megakaryocyte Frequency and Platelet Count

Martin U. Kuefer(St. Jude Children's Research Hospital), Carl W. Jackson(St. Jude Children's Research Hospital), Wayne L. Furman(St. Jude Children's Research Hospital), Dawn M. Best(St. Jude Children's Research Hospital), Winfred C. Wang(St. Jude Children's Research Hospital), David R. Head(University of Southern California), A Hornkohl(St. Jude Children's Research Hospital), Qing Liu(Tongji University), Judith A. Wilimas
Journal of Pediatric Hematology/Oncology
January 1, 1998
10.1097/00043426-199801000-00006
Cited by 12

Related Papers

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
Age and acute myeloid leukemia
|Blood|2006|1.4k
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
|Blood|1997|869
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.
|Journal of Clinical Oncology|1990|786
Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia
|New England Journal of Medicine|1991|722